Skip to main content
Log in

Adalimumab/infliximab

Histoplasmosis: 5 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Dotson JL, Crandall W, Mousa H, Honegger JR, Denson L, Samson C, Cunningham D, Balint J, Dienhart M, Jaggi P, Carvalho R.Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: A case series. Inflammatory Bowel Diseases 17: e56-61, No. 1, Jan 2011. Available from: URL: http://dx.doi.org/10.1002/ibd.21378 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adalimumab/infliximab. React. Wkly. 1336, 5 (2011). https://doi.org/10.2165/00128415-201113360-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113360-00011

Keywords

Navigation